COMBINING OUR EXPERTISE WITH CU-TECH TO CREATE THE LEADING DERMATOLOGY CRO

We Are the Leading Dermatology CRO

COMBINING OUR EXPERTISE WITH CU-TECH TO CREATE THE LEADING DERMATOLOGY CRO

We have performed, over our combined history:

  • 230+  Clinical Trials
  • 20+ Indications
  • 1,200 Sites
  • 57,500 Patients

With the acquisition of dermatology specialist CRO Cu-Tech, we add another focused center of development, and another East coast office. Together, Synteract and Cu-Tech have conducted more than 230+ dermatology studies. With our combined dermatology knowledge across multiple indications, and strong relationships with clients and investigators, we are uniquely positioned to work in the development of products related to dermatologic diseases such as psoriasis, atopic dermatitis, acne, alopecia, skin cancer and numerous other indications, as well as skin care products.

The combination of Cu-Tech and Synteract forms the leading CRO in dermatology and will greatly enhance the expertise available to customers

Contact Us to see how we can help bring your dermatology clinical trials to life!

x

Contact Synteract

Tell us how to stay in touch with you:

*Required